142 related articles for article (PubMed ID: 28770638)
1. Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules.
Galgani I; Bunge EM; Hendriks L; Schludermann C; Marano C; De Moerlooze L
Expert Rev Vaccines; 2017 Sep; 16(9):919-932. PubMed ID: 28770638
[TBL] [Abstract][Full Text] [Related]
2. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
[TBL] [Abstract][Full Text] [Related]
3. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).
Schoendorf I; Ternak G; Oroszlàn G; Nicolay U; Banzhoff A; Zent O
Hum Vaccin; 2007; 3(2):42-7. PubMed ID: 17297298
[TBL] [Abstract][Full Text] [Related]
4. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
[TBL] [Abstract][Full Text] [Related]
5. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
Beran J; Xie F; Zent O
Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
[TBL] [Abstract][Full Text] [Related]
6. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
Wittermann C; Schöndorf I; Gniel D
Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
8. Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up.
Beran J; Lattanzi M; Costantini M; Pammolli A; Galgani I
Vaccine; 2023 May; 41(23):3518-3524. PubMed ID: 37142462
[TBL] [Abstract][Full Text] [Related]
9. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): A systematic review.
Rampa JE; Askling HH; Lang P; Zens KD; Gültekin N; Stanga Z; Schlagenhauf P
Travel Med Infect Dis; 2020; 37():101876. PubMed ID: 32931931
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.
Zent O; Jilg W; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Banzhoff A
Vaccine; 2003 Dec; 21(32):4655-60. PubMed ID: 14585672
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
Wittermann C; Petri E; Zent O
Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
[TBL] [Abstract][Full Text] [Related]
14. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.
Beran J; Douda P; Gniel D; Zent O
Int J Med Microbiol; 2004 Apr; 293 Suppl 37():130-3. PubMed ID: 15146994
[TBL] [Abstract][Full Text] [Related]
16. Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.
Costantini M; Callegaro A; Beran J; Berlaimont V; Galgani I
Hum Vaccin Immunother; 2020 Sep; 16(9):2274-2279. PubMed ID: 31951780
[TBL] [Abstract][Full Text] [Related]
17. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
[TBL] [Abstract][Full Text] [Related]
18. Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine.
Hopf S; Garner-Spitzer E; Hofer M; Kundi M; Wiedermann U
Vaccine; 2016 Apr; 34(17):2027-34. PubMed ID: 26768126
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
[TBL] [Abstract][Full Text] [Related]
20. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
Steffen R; Erber W; Schmitt HJ
Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
